Most bought healthcare stocks in Q1 2015
See which Healthcare stocks institutional investors increased the most in Q1 2015, measured as net growth in reported share positions from Q4 2014 into Q1 2015. Notable additions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), ILLUMINA INC (ILMN), GILEAD SCIENCES INC (GILD), BAXTER INTERNATIONAL INC (BAX). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3,155,285 | $215.51M | 2 | 4 | 0 | 0 | 6 |
| ILMN | ILLUMINA INC | 2,752,794 | $520.75M | 1 | 1 | 1 | 0 | 5 |
| GILD | GILEAD SCIENCES INC | 2,183,180 | $251.63M | 0 | 7 | 7 | 0 | 14 |
| BAX | BAXTER INTERNATIONAL INC | 2,004,859 | $87.78M | 1 | 3 | 3 | 0 | 9 |
| DVA | DAVITA INC | 1,903,108 | $442.27M | 0 | 2 | 2 | 0 | 6 |
| PFE | PFIZER INC | 1,711,282 | $288.32M | 1 | 1 | 9 | 1 | 13 |
| DHR | DANAHER CORP | 1,513,443 | $114.32M | 1 | 1 | 2 | 0 | 5 |
| ZTS | ZOETIS INC | 1,425,793 | $206.77M | 0 | 2 | 0 | 0 | 4 |
| OPK | OPKO HEALTH INC | 1,253,398 | $17.76M | 1 | 0 | 0 | 0 | 1 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,165,267 | $136.83M | 1 | 1 | 0 | 0 | 2 |
| LLY | ELI LILLY & CO | 901,082 | $101.26M | 1 | 0 | 4 | 0 | 6 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 874,505 | $31.17M | 0 | 2 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 866,500 | $54.80M | 0 | 1 | 0 | 0 | 2 |
| AMRN | AMARIN CORP PLC -ADR | 732,490 | $1.71M | 1 | 0 | 0 | 0 | 1 |
| GERN | GERON CORP | 605,265 | $3.09M | 0 | 1 | 1 | 0 | 2 |
| PRGO | Perrigo Company PLC | 557,727 | $86.45M | 0 | 3 | 1 | 0 | 4 |
| MOH | MOLINA HEALTHCARE INC | 527,200 | $37.99M | 0 | 1 | 0 | 0 | 1 |
| CVS | CVS HEALTH CORP | 433,839 | $90.91M | 1 | 1 | 6 | 1 | 9 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 414,100 | $10.47M | 0 | 1 | 0 | 0 | 2 |
| CNC | CENTENE CORP | 393,900 | $23.81M | 0 | 1 | 0 | 0 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | 392,997 | $853.00K | 0 | 1 | 0 | 0 | 1 |
| AMN | AMN HEALTHCARE SERVICES INC | 363,800 | $8.60M | 0 | 1 | 0 | 0 | 1 |
| A | AGILENT TECHNOLOGIES INC | 339,138 | $16.84M | 0 | 1 | 1 | 0 | 3 |
| AMGN | AMGEN INC | 316,678 | $57.27M | 1 | 1 | 4 | 0 | 7 |
| UTHR | UNITED THERAPEUTICS CORP | 273,662 | $70.61M | 0 | 2 | 0 | 0 | 2 |
| ENZ | ENZO BIOCHEM INC | 269,306 | -$613.00K | 0 | 1 | 0 | 0 | 1 |
| WAT | WATERS CORP | 253,650 | $62.80M | 1 | 2 | 1 | 0 | 4 |
| OMI | OWENS & MINOR INC | 251,310 | $7.25M | 0 | 2 | 0 | 0 | 2 |
| CARA | CARA THERAPEUTICS INC | 248,882 | $2.50M | 0 | 1 | 0 | 0 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 232,261 | $2.89M | 0 | 1 | 0 | 0 | 1 |
| BRKR | BRUKER CORP | 226,310 | $4.18M | 1 | 0 | 0 | 0 | 1 |
| BMY | BRISTOL-MYERS SQUIBB CO | 203,482 | $18.41M | 2 | 2 | 3 | 1 | 10 |
| VNDA | VANDA PHARMACEUTICALS INC | 195,100 | $1.81M | 1 | 0 | 0 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | 192,060 | $109.07M | 1 | 1 | 0 | 0 | 2 |
| MMSI | MERIT MEDICAL SYSTEMS INC | 190,714 | $3.82M | 0 | 1 | 0 | 0 | 1 |
| RGEN | REPLIGEN CORP | 165,861 | $12.37M | 0 | 1 | 0 | 0 | 1 |
| ISRG | INTUITIVE SURGICAL INC | 152,210 | $70.86M | 0 | 1 | 1 | 0 | 3 |
| HALO | HALOZYME THERAPEUTICS INC | 146,670 | $20.93M | 0 | 1 | 1 | 0 | 2 |
| CDXS | CODEXIS INC | 145,000 | $1.31M | 0 | 1 | 0 | 0 | 1 |
| INGN | INOGEN INC | 142,900 | $4.58M | 0 | 1 | 0 | 0 | 1 |
| CRL | CHARLES RIVER LABORATORIES | 139,113 | $49.35M | 0 | 1 | 1 | 1 | 2 |
| ESPR | ESPERION THERAPEUTICS INC | 136,919 | $12.68M | 1 | 0 | 0 | 0 | 1 |
| CERS | CERUS CORP | 136,000 | $567.00K | 1 | 0 | 0 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 135,900 | -$3.40M | 0 | 1 | 0 | 0 | 2 |
| ALKS | ALKERMES PLC | 134,700 | $8.37M | 0 | 1 | 0 | 0 | 1 |
| AMPH | AMPHASTAR PHARMACEUTICALS IN | 123,380 | $1.85M | 1 | 0 | 0 | 0 | 1 |
| STXS | STEREOTAXIS INC | 121,600 | $270.00K | 0 | 1 | 0 | 0 | 1 |
| BIO | BIO-RAD LABORATORIES-A | 115,575 | $32.33M | 0 | 2 | 0 | 0 | 2 |
| NEO | NEOGENOMICS INC | 107,700 | $571.00K | 0 | 1 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 106,467 | -$73.54M | 0 | 6 | 10 | 0 | 20 |
Frequently asked questions about Most bought healthcare stocks in Q1 2015
What are the most bought Healthcare stocks in Q1 2015?
The most bought healthcare stocks in Q1 2015 are those with the largest increase in reported share counts across institutional investors compared to Q4 2014, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2015?
Among filers in this sector, net additions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), ILLUMINA INC (ILMN), GILEAD SCIENCES INC (GILD), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2014).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.